These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25428381)

  • 61. Nectin-1 expression in cancer-associated fibroblasts is a predictor of poor prognosis for pancreatic ductal adenocarcinoma.
    Yamada M; Hirabayashi K; Kawanishi A; Hadano A; Takanashi Y; Izumi H; Kawaguchi Y; Mine T; Nakamura N; Nakagohri T
    Surg Today; 2018 May; 48(5):510-516. PubMed ID: 29256146
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Paraneoplastic Ma Antigen-Like 1 as a Potential Prognostic Biomarker in Human Pancreatic Ductal Adenocarcinoma.
    Kuwae Y; Kakehashi A; Wakasa K; Wei M; Yamano S; Ishii N; Ohsawa M; Wanibuchi H
    Pancreas; 2015 Jan; 44(1):106-15. PubMed ID: 25251443
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Expression of B cell transposition gene 3 in pancreatic ductal adenocarcinoma and its prognostic value].
    Chen J; Zhou ZC; Liu WB; Wang J; Chen XJ; Shen YY; Zhong ZX
    Zhonghua Wai Ke Za Zhi; 2017 Nov; 55(11):863-867. PubMed ID: 29136736
    [No Abstract]   [Full Text] [Related]  

  • 64. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
    Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression and significance of CD44 and p-AKT in pancreatic head cancer.
    Xiaoping L; Xiaowei Z; Leizhen Z; Weijian G
    World J Surg Oncol; 2015 Dec; 13():334. PubMed ID: 26666511
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma.
    Yang JY; Jiang SH; Liu DJ; Yang XM; Huo YM; Li J; Hua R; Zhang ZG; Sun YW
    Sci Rep; 2015 May; 5():10575. PubMed ID: 26015068
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
    Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunohistochemical expression of NEDD9, E-cadherin and γ-catenin and their prognostic significance in pancreatic ductal adenocarcinoma (PDAC).
    Radulović P; Krušlin B
    Bosn J Basic Med Sci; 2018 Aug; 18(3):246-251. PubMed ID: 29924959
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
    Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
    Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome.
    Kim JC; Kim KT; Park JT; Kim HJ; Sato Y; Kim HS
    Hepatogastroenterology; 2015; 62(138):251-6. PubMed ID: 25916042
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High nuclear Survivin expression as a poor prognostic marker in pancreatic ductal adenocarcinoma.
    Zhou L; Lu J; Liang ZY; Zhou WX; Yuan D; Li BQ; You L; Guo JC; Zhao YP
    J Surg Oncol; 2018 Dec; 118(7):1115-1121. PubMed ID: 30261114
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased FAT10 expression is related to poor prognosis in pancreatic ductal adenocarcinoma.
    Sun GH; Liu YD; Yu G; Li N; Sun X; Yang J
    Tumour Biol; 2014 Jun; 35(6):5167-71. PubMed ID: 24492942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic Impact of Cell Division Cycle Associated 2 Expression on Pancreatic Ductal Adenocarcinoma.
    Wang MY; Niu ZY; Gao XG; Zhou L; Liao Q; Zhao YP
    Chin Med Sci J; 2016 Sep; 31(3):149-154. PubMed ID: 27733221
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma.
    Huo Y; Yang M; Liu W; Yang J; Fu X; Liu D; Li J; Zhang J; Hua R; Sun Y
    J Exp Clin Cancer Res; 2015 Aug; 34(1):88. PubMed ID: 26297342
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.
    Li C; Zhao Z; Zhou Z; Liu R
    Dig Dis Sci; 2016 Mar; 61(3):767-73. PubMed ID: 26500118
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cytoglobin as a Prognostic Factor for Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis of 75 Patients.
    Kono H; Hosomura N; Amemiya H; Kawaida H; Furuya S; Akaike H; Kawaguchi Y; Sudo M; Ichikawa D
    Pancreas; 2021 Aug; 50(7):994-999. PubMed ID: 34629450
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarcinoma.
    Isohookana J; Haapasaari KM; Soini Y; Leppänen J; Karihtala P
    Pathol Res Pract; 2018 Jun; 214(6):840-847. PubMed ID: 29735403
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinicopathological significance of Necl-4 expression in pancreatic ductal adenocarcinoma.
    Kawanishi A; Hirabayashi K; Yamada M; Takanashi Y; Hadano A; Kawaguchi Y; Nakagohri T; Nakamura N; Mine T
    J Clin Pathol; 2017 Jul; 70(7):619-624. PubMed ID: 27980052
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion.
    Lenz J; Karasek P; Jarkovsky J; Muckova K; Dite P; Kala Z; Veselska R; Hermanova M
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):389-96. PubMed ID: 22187705
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma.
    Askan G; Sahin IH; Chou JF; Yavas A; Capanu M; Iacobuzio-Donahue CA; Basturk O; O'Reilly EM
    BMC Cancer; 2021 Apr; 21(1):385. PubMed ID: 33836674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.